Invention Grant
- Patent Title: Methods of treating psoriatic arthritis using IL-17 antagonists
-
Application No.: US15654854Application Date: 2017-07-20
-
Publication No.: US10363307B2Publication Date: 2019-07-30
- Inventor: Shephard Mpofu , Hanno Richards , Karthinathan Thangavelu , Matthias Machacek
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Leslie Fischer
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/519 ; C07K16/24 ; A61K45/06 ; A61K39/00
Abstract:
The disclosure relates to novel regimens for treating an inflammatory arthritis, e.g., psoriatic arthritis, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., IL-17 binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof, e.g., secukinumab) or IL-17 receptor binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof).
Public/Granted literature
- US20180008706A1 METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS Public/Granted day:2018-01-11
Information query
